US Government Calls For Additional 200M Doses Of Pfizer-BioNTech COVID Shot
The U.S. government has purchased an additional 200 million doses of the Pfizer Inc (NYSE:PFE) – BioNTech SE (NASDAQ:BNTX) COVID-19 Vaccine. The incremental doses…
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
Pfizer And BioNTech To Provide US Government With Additional 200M Doses Of COVID-19 Vaccine To Help Meet Continued Need For Vaccine Supply In The US; Financial Terms Not Disclosed
Dose deliveries for new order expected to occur from October 2021 through April 2022
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) today announced that the U.S. government has purchased an additional 200 million
Johnson & Johnson’s COVID-19 Shot Is Less Effective Against Delta Variant: Study
As the Delta variant rapidly spreads across the U.S., accounting for 83% of the country's cases, a new study showed that neutralizing titers induced by Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine
Alzheimer’s Approval, COVID-19 Vaccines Put Spotlight On Biotech Sector, But What’s Next?
For most of the past year, just a handful of companies carried the biotech sector, thanks to their quick responses to the COVID-19 pandemic.
Stocks That Hit 52-Week Highs On Wednesday
During Wednesday's morning trading, 125 companies set new 52-week highs.
Pfizer/BioNTech Strike COVID-19 Manufacturing Deal With Biovac For South Africa
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have struck a deal with South Africa’s Biovac Institute to process and distribute over 100 million…